Rejuve Biotech utilizes advanced AI and rich cross-organism data to provide innovative therapeutics for longevity and age-related diseases. By leveraging data from long-lived animal models like Methuselah flies along with crowdsourced human datasets, they aim to shorten the drug discovery pipeline and generate effective longevity treatments. The platform uniquely integrates neural, symbolic, and evolutionary AI to analyze biological data, enabling rapid development of healthspan-enhancing products and potential treatments for diseases like Alzheimer's. Their approach signals a shift in how aging and associated diseases are understood and targeted, using multidisciplinary insights from biogerontology and advanced Computational Intelligence.
• ai-driven drug discovery
• crowdsourced human data
• community of scientists using ai for research
• designed for aging and age-associated diseases
• rapid development of therapeutics
• use of long-lived animal models
• integration of neural-symbolic ai
• Participation in research funding
• Access to exclusive data
• Join a community of researchers
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
No ratings available.
A federated AI framework that integrates decentralized data sources for AI development.
View DetailsTransform unstructured data into structured knowledge for accurate AI solutions.
View Details